Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 235,007,679 papers from all fields of science
Search
Sign In
Create Free Account
Multi-glioblastoma-peptide-targeting Autologous Dendritic Cell Vaccine ICT-107
Known as:
ICT-107
, Multi-glioblastoma-peptide-pulsed Autologous DC Vaccine ICT-107
, Multi-glioblastoma-peptide-targeting Autologous DC Vaccine ICT-107
A cell-based cancer vaccine composed of autologous dendritic cells (DCs) pulsed with six synthetic glioblastoma (GBM) peptides: absent in melanoma 2…
Expand
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
ATIM-25. TEN-YEAR FOLLOW UP WITH LONG TERM REMISSION IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM) TREATED WITH ICT-107 VACCINE (PHASE I)
S. Phuphanich
,
C. Wheeler
,
+7 authors
John S. Yu
2016
Corpus ID: 78994025
2014
2014
ImmunoCellular Therapeutics to Present at Livingston Securities Conference on October 1, 2014
Andrew Gengos
2014
Corpus ID: 74262442
To access the live audio webcast of the Livingston Securities presentation, please log on through a link located in the Investors…
Expand
Review
2010
Review
2010
FDA Pipeline Preview, August 2010 (Naproxcinod, Ticagrelor, Phenoxodiol, CBLB502, TOL101, Oral kinase inhibitor, GVAX CML vaccine, TXA127, Sapacitabine or CYC682, ICT-107, Perifosine or KRX-0401…
F. Staff
2010
Corpus ID: 70988455
Recent FDA action (through, July 2010) related to Naproxcinod, Ticagrelor, Phenoxodiol, CBLB502, TOL101, Oral kinase inhibitor…
Expand